The role of CD45 and CD45-associated molecules in T cell activation

Immunology and Cell Biology

Volumn 75, Issue 5, 1997, Pages 430-445

  Altin, Joseph G ^a   Sloan, Erica K ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

CD45; Ligands; Molecular associations; T cell activation; T cell receptor signalling

Indexed keywords

CD45 ANTIGEN;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; IMMUNOSTIMULATION; NONHUMAN; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0030664027     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.68     Document Type: Review

References (216)

1. Perlmutter RM, Levin SD, Appleby MW, Anderson SJ, Alberola-Ila J. Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 1993; 11: 451-99.
2. Malissen B, Schmitt-Verhulst A-M. Transmembrane signalling through the T cell receptor-CD3 complex. Curr. Opin. Immunol. 1993; 5: 324-33.
3. Kaufman JF, Auffray C, Korman AJ, Shackelford DA, Strominger JL. The class II molecules of the human and murine major histocompatibility complex. Cell 1994; 36: 1-13.
4. Miceli MC, Parnes JR. CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 1993; 53: 59-122.
5. Collins TL, Hahn WC, Bierer BE, Burakoff SJ. The role of CD4, CD8 and CD2 in T cell activation. Curr. Top. Microbiol. Immunol. 1993; 184: 223-33.
6. Springer TA. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu. Rev. Cell Biol. 1990; 6: 359-402.
7. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 1991; 9: 27-66.
8. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 366: 425-8.
9. Bierer BE, Burakoff SJ. T-lymphocyte activation: the biology and function of CD2 and CD4. Immunol. Rev. 1989; 111: 267-94.
10. Mondino A, Jenkins MC. Surface proteins involved in T cell costimulation. J. Leuk. Biol. 1994; 55: 805-15.
11. Fidgor CG, van Kooyk Y, Keizer GD. On the mode of action of LFA-1. Immunol. Today. 1990; 11: 277-80.
12. Moingeon PE, Lucich JL, Stebbins CC et al. Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation Eur. J. Immunol. 1991; 21: 605-10.
13. Sen J, Bossu P, Burakoff SJ, Abbas AK. T cell surface molecules regulating non-cognate B lymphocyte activation: role of CD2 and LFA-1. J. Immunol. 1992; 148: 1037-42.
14. Fawcett J, Holness CLL, Needham LA et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992; 360: 481-4.
15. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321-31.
16. Wingren AG, Parra E, Varga M et al. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit. Rev. Immunol. 1995; 15: 235-47.
17. Owens T. T-cell costimulation: T cells themselves call the shots. Curr. Biol. 1996; 6: 32-5.
18. Thomas ML. The leukocyte common antigen family. Annu. Rev. Immunol. 1989; 7: 339-69.
19. Trowbridge IS, Ostergaard HL, Johnson P. CD45: a leukocyte-specific member of the protein tyrosine phosphatase family. Biochim. Biophys. Acta 1991; 1095: 46-56.
20. Fischer EH, Charbonneau H, Tonks NK. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991; 253: 401-6.
21. Alexander D, Shiroo M, Robinson A, Biffen M, Shivnan E. The role of CD45 in T cell activation: resolving the paradoxes? Immunol. Today 1992; 13: 477-81.
22. Koretzky GA, Kohmetscher MA, Kadleck T, Weiss A. Restoration of T cell receptor-mediated signal transduction by transfection of CD45 cDNA into a CD45-deficient variant of the Jurkat T cell line. J. Immunol. 1992; 149: 1138-42.
23. Fraser JD, Straus D, Weiss A. Signal transduction events leading to T-cell lymphokine gene expression. Immunol. Today 1993; 14: 357-62.
24. Janeway CA Jr, Goldstein P. Lymphocyte activation and effector functions: the role of cell surface molecules. Curr. Opin. Immunol. 1993; 5: 313-23.
25. Trowbridge IS. CD45: A prototype for transmembrane protein tyrosine phosphatases. J. Biol. Chem. 1991; 266: 23 517-20.
26. Fischer EH, Charbonneau H, Tonks NK. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991; 253: 401-6.
27. Isakov N. Tyrosine phosphorylation and dephosphorylation in T lymphocyte activation. Mol. Immunol. 1993; 30: 197-210.
28. Pulido R, Sanchez-Madrid F. Glycosylation of CD45: carbohydrate processing through Golgi apparatus is required for cell surface expression and protein stability. Eur. J. Immunol. 1992; 22: 463-8.
29. Sato T, Furukawa K, Autero M, Gahmberg CG, Kobata A. Structural study of the sugar chains of human leukocyte common antigen CD45. Biochemistry 1993; 32: 12 694-704.
30. Okumura M, Matthews RJ, Robb B, Litman GW, Bork P, Thomas ML. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggest the conservation of three fibronectin type III domains. J. Immunol. 1996; 157: 1569-75.
31. Ohta T, Kitamura K, Maizel AL, Takeda A. Alterations in CD45 glycosylation pattern accompanying different cell proliferation states. Biochem. Biophys. Res. Commun. 1994; 200: 1283-9.
32. Baum LG, Derbin K, Perillo NL, Wu T, Pang M, Uittenbogaart C. Characterization of terminal sialic acid linkages on human thymocytes: Correlation between lectin-binding phenotype and siayltransferase expression. J. Biol. Chem. 1996; 271: 10793-9.
33. Giordanengo V, Limouse M, Peyron J-F, Lefebvre J-C. Lymphocytic CD43 and CD45 bear sulfate residues potentially implicated in cell to cell interactions. Eur. J. Immunol. 1995; 25: 274-8.
34. Cyster JG, Fowell D, Barclay AN. Antigenic determinants encoded by alternative spliced exons of CD45 are determined by the polypeptide but influenced by glycosylation. Int. Immunol. 1994; 6: 1875-81.
35. Poppema S, Lai R, Visser L, Yan XJ. CD45 (leucocyte common antigen) expression in T and B lymphocyte subsets. Leuk. Lymphoma 1996; 20: 217-22.
36. Tan X, Stover DR, Walsh KA. Demonstration of protein tyrosine phosphatase activity in the second of two homologous domains of CD45. J. Biol. Chem. 1993; 268: 6835-8.
37. Johnson P, Ostergaard HL, Wasden C, Trowbridge IS. Mutational analysis of CD45: A leukocyte-specific protein tyrosine phosphatase. J. Biol. Chem. 1992; 267: 8035-41.
38. Ng DH, Maiti A, Johnson P. Point mutation in the second phosphatase domain of CD45 abrogates tyrosine phosphatase activity. Biochem. Biophys. Res. Commun. 1995; 206: 302-9.
39. Hathcock KS, Laszlo G, Dickler HB et al. Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations. J. Immunol. 1992; 148: 19-28.
40. + T cell subsets. J. Allergy Clin. Immunol. 1996; 98: 433-40.
41. h2 cell lines. Eur. J. Immunol. 1992; 22: 1455-9.
42. Chang H-L, Lefrancois L, Zaroukian MH, Esselman WJ. Developmental expression of CD45 alternate exons in murine T cells. J. Immunol. 1991; 147: 1687-93.
43. Fujii Y, Okumura M, Inada K, Nakahara K, Matsuda H. CD45 isoform expression during T cell development in the thymus. Eur. J. Immunol. 1992; 22: 1843-50.
44. Kirberg J, Brocker T. CD45 up-regulation during lymphocyte maturation. Int. Immunol. 1996; 8: 1743-9.
45. Birkeland ML, Johnson P, Trowbridge IS, Pure E. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Prof. Natl Acad. Sci. USA 1989; 86: 6734-8.
46. Warren HS, Skipsey LJ. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells. Immunology 1991; 74: 78-85.
47. Ogawa Y, Okazaki H, Sudo T et al. High-molecular-weight Ly-5 isoforms expressed on T cells: activation-dependent expression. Int. Immunol. 1991; 3: 39-47.
48. Pinto L, Covas MJ, Victorino RM. Loss of CD45RA and gain of CD45RO after in vitro activation of lymphocytes from HIV-infected patients. Immunology 1991; 73: 147-50.
49. Mahalingam M, Pozniak A, McManus TJ, Senaldi G, Virgani D, Peakman M. Abnormalities of CD45 isoform expression in HIV infection. Clin. Immunol. Immunopathol. 1996; 81: 210-14.
50. + cells with different requirements for activation and differentiation. J. Immunol. 1991; 146: 2088-94.
51. + T cells differing in CD45R expression. J. Immunol. 1992; 149: 2300-6.
52. + lymphocytes. Eur. J. Immunol. 1995; 25: 644-8.
53. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells. Immunol. Today 1988; 9: 195-8.
54. Bell EB, Sparshott SM. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature 1990; 348: 163-6.
55. Beverley P. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin. Immunol. 1992; 4: 35-41.
56. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 1994; 12: 85-116.
57. + thymocytes into mature T cells. Proc. Natl Acad. Sci. USA 1994; 91: 6933-7.
58. Oravecz T, Monostori E, Kurucz E, Takacs L, Ando I. CD3-induced T cell proliferation and interleukin-2 secretion is modulated by the CD45 antigen. Scand. J. Immunol. 1991; 34: 531-7.
59. Nel AE, Ledbetter JA, Williams K et al. Activation of MAP-2 kinase activity by the CD2 receptor in Jurkat T cells can be reversed by CD45 phosphatase. Immunology 1991; 73: 129-33.
60. Naora H, Altin JG, Young IG. TCR-dependent and -independent signalling mechanisms differentially regulate lymphokine gene expression in the murine T helper clone D10.G4.1. J. Immunol. 1994; 152: 5691-702.
61. Shivnan E, Clayton L, Allridge L, Keating KE, Gullberg M, Alexander DR. CD45 monoclonal antibodies inhibit TCR-mediated calcium signals, calmodulin-kinase IV/Gr activation, and oncoprotein 18 phosphorylation. J. Immunol. 1996; 157: 101-9.
62. Ong CJ, Chui D, Teh HS, Marth JD. Thymic CD45 tyrosine phosphatase regulates apoptosis and MHC-restricted negative selection. J. Immunol. 1994; 152: 3793-805.
63. Klaus SJ, Sidorenko SP, Clark EA. CD45 ligation induces programmed cell death in T and B lymphocytes. J. Immunol. 1996; 156: 2743-53.
64. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc. Natl Acad. Sci USA 1991; 88: 2037-41.
65. Bernard G, Zoccola D, Ticchioni M, Breittmayer J-P, Aussel C, Bernard A. Engagement of the CD45 molecule induces homotypic adhesion of human thymocytes through a LFA-1/ICAM-3-dependent pathway. J. Immunol. 1994; 152: 5161-70.
66. Lorenz H-M, Lagoo AS, Hardy KJ. The cell and molecular basis of leukocyte common antigen (CD45)-triggered, lymphocyte function-associated antigen-1-/intercellular adhesion molecule-1-dependent, leukocyte adhesion. Blood 1994; 83: 1862-70.
67. Wagner N, Engel P, Tedder TF. Regulation of the tyrosine kinase-dependent adhesion pathway in human lymphocytes through CD45. J. Immunol. 1993; 150: 4887-99.
68. Spertini F, Wang AVT, Chatila T, Geha RS. Engagement of the common leukocyte antigen CD45 induces homotypic adhesion of activated human T cells. J. Immunol. 1994; 153: 1593-602.
69. Arroyo AG, Campanero MR, Sanchez-Mateos P et al. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase. J. Cell Biol. 1994; 126: 1277-86.
70. lck-associated proteins in T cells. J. Immunol. 1995; 155: 5095-103.
71. Stibenz D, Buhrer C, Laufer D, Obladen M. CD45 engagement induces L-selectin down-regulation. Scand. J. Immunol. 1996; 44: 37-44.
72. Parish CR, Hogarth PM, McKenzie IFC. Evidence that Thy1 and Ly-5 (T200) antigens interact with sulphated carbohydrates. Immunol. Cell Biol. 1988; 66: 221-30.
73. Coombe DR, Watt SM, Parish CR. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 1994; 84: 739-52.
74. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and α2-6 sialyltransferase, CD75, on B cells. Cell 1991; 66: 1133-44.
75. Stamenkovic I, Seed B. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990; 345: 74-7.
76. Sgroi D, Varki A, Braesch-Andersen S, Stamenkovic I. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J. Biol. Chem. 1993; 268: 7011-18.
77. Law C-L, Sidorenko SP, Clark EA. Regulation of lymphocyte activation by the cell-surface molecule CD22. Immunol. Today 1994; 15: 442-9.
78. Aruffo A, Kanner SB, Sgroi D, Ledbetter JA. Stamenkovic I. CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signalling. Proc. Natl Acad. Sci. USA 1992; 89: 10 242-6.
79. Justement LB, Brown VK, Lin J. Regulation of B-cell activation by CD45: a question of mechanism. Immunol. Today 1994; 15: 399-406.
80. Sgroi D, Stamenkovic I. The B-cell adhesion molecule CD22 is cross-species reactive and recognizes distinct sialo-glycoproteins on different functional T-cell sub-populations. Scand. J. Immunol. 1994; 39: 433-8.
81. Powell LD, Sgroi D, Sjoberg ER, Stamenkovic I, Varki A. Natural ligands of the B cell adhesion molecule CD22β carry N-linked oligosaccharides with α-2,6-linked sialic acids that are required for recognition. J. Biol. Chem. 1993; 268: 7019-27.
82. Engel P, Nojima Y, Rothstein D et al. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J. Immunol. 1993; 150: 4719-32.
83. Sgroi D, Koretzky GA, Stamenkovic I. Regulation of CD45 engagement by the B-cell receptor CD22. Proc. Natl Acad. Sci. USA 1995; 92: 4026-30.
84. Clark EA. CD22, a B cell-specific receptor, mediates adhesion and signal transduction. J. Immunol. 1993; 150: 4715-18.
85. Uemura K, Yokota Y, Kozutsumi Y, Kawasaki T. A unique CD45 glycoform recognized by the serum mannan-binding protein in immature thymocytes. J. Biol. Chem. 1996; 271: 4581-4.
86. Powell LD, Varki A. I-type lectins. J. Biol. Chem. 1995; 270: 14 243-6.
87. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J. 1992; 6: 861-70.
88. Volarevic S, Burns CM, Sussman JJ, Ashwell JD. Intimate association of Thy-1 and the T-cell antigen receptor with CD45 tyrosine phosphatase. Proc. Natl Acad. Sci. USA 1990; 87: 7085-9.
89. Altin G, Pagler EB. A one-step procedure for biotinylation and chemical cross-linking of lymphocyte surface and intracellular membrane-associated molecules. Anal. Biochem. 1995; 224: 382-9.
90. Schraven B, Samstag Y, Altevogt P, Meuer SC. Association of CD2 and CD45 on human T lymphocytes. Nature 1990; 345: 71-5.
91. Altevogt P, Schreck J, Schraven B, Meuer S, Schirrmacher V, Mitsch A. Association of CD2 and T200 (CD45) in mouse T lymphocytes. Int. Immunol. 1990; 2: 353-60.
92. Altin JG, Pagler EB, Parish CR. Evidence for cell surface association of CD2 and LFA-1 (CD11a/CD18) on T lymphocytes. Eur. J. Immunol. 1994; 24: 450-7.
93. Lazarovits AI, Osman N, Le Feuvre CE, Ley SC, Crumpton MJ. CD7 is associated with CD3 and CD45 on human T cells. J. Immunol. 1994; 153: 3956-66.
94. Furukawa T, Itoh M, Krueger NX, Streuli M, Saito H. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3ζ chain. Proc. Natl Acad. Sci. USA 1994; 91: 10928-32.
95. i (TCR)/ CD3 complexes. Eur. J. Immunol. 1991; 21: 1663-8.
96. Mittler RS, Rankin BM, Kiener PA. Physical associations between CD45 and CD4 or CD8 occur as late activation events in antigen receptor-stimulated human T-cells. J. Immunol. 1991; 147: 3434-40.
97. Dianzani U, Redoglia V, Malavasi F et al. Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur. J. Immunol. 1992; 22: 365-71.
98. Leitenberg D, Novak TJ, Farber D, Smith BR, Bottomly K. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J. Exp. Med. 1996; 183: 249-59.
99. Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J. Immunol. 1991; 147: 2514-17.
100. Zocchi MR, Poggi A, Crosti F, Tongiani S, Rugarli C. Signalling in human tumor infiltrating lymphocytes: the CD28 molecule is functional and is physically associated with the CD45RO molecule. Eur. J. Cancer 1992; 28A: 749-54.
101. Hérold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L. CD100 is associated with CD45 at the surface of human T lymphocytes. J. Immunol. 1996; 157: 5262-8.
102. Bourguignon LYW, Suchard SJ, Nagpal ML, Glenney JR Jr. A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin. J. Cell Biol. 1985; 101: 477-87.
103. Suchard SJ, Bourguignon LYW. Further characterization of a fodrin-containing transmembrane complex from mouse T lymphoma cells. Biochim. Biophys. Acta 1987; 896: 35-46.
104. lck and pp32, a possible common substrate. Eur. J. Immunol. 1991; 21: 2469-77.
105. lck-associated phosphoproteins (pp29-pp32) undergo alterations in human T cell activation. Eur. J. Immunol. 1992; 22: 1857-63.
106. Lee JM, Fournel M, Veillette A, Branton PE. Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines. Oncogene 1996; 12: 253-63.
107. Arendt CW, Ostergaard HL. CD45 protein tyrosine phosphatase is specifically associated with 116 kDa tyrosine phosphorylated glycoprotein. J. Biol. Chem. 1995; 270: 2313-19.
108. Schraven B, Schoenhaut D, Bruyns E et al. LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J. Biol. Chem. 1994; 269: 29 102-11.
109. Altin JG, Pagler EB, Parish CR. Evidence for an association of CD45 with 32 000-33 000 MW phosphoproteins on murine T and B cells. Immunology 1994; 83: 420-9.
110. Takeda A, Maizel A, Kitamura K, Ohta T, Kimura S. Molecular cloning of the CD45-associated 30 kDa protein. J. Biol. Chem. 1994; 269: 2357-60.
111. Brown VK, Ogle EW, Burkhardt AL, Rowley RB, Bolen JB, Justement LB. Multiple components of the B cell antigen receptor complex associate with the protein tyrosine phosphatase, CD45. J. Biol. Chem. 1994; 269: 17 238-44.
112. Justement LB, Campbell KS, Chien NC, Cambier JC. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 1991; 252: 1839-42.
113. Yanagi S, Sugawara H, Kurosaki M, Sabe H, Yamamura H, Kurosaki T. CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells. J. Biol. Chem. 1996; 271: 30 487-92.
114. Altin JG, Pagler EB, Kinnear BF, Warren HS. Molecular associations involving CD16, CD45 and ζ and γ chains on human natural killer cells. Immunol. Cell Biol. 1994; 72: 87-96.
115. lck-mediated tyrosine phosphorylation and IFN-gamma production. J. Immunol. 1995; 155: 5241-8.
116. Pingel JT, Cahir McFarland ED, Thomas ML. Activation of CD45-deficient T cell clones by lectin mitogens but not anti-Thy-1. Int. Immunol. 1994; 6: 169-78.
117. Dianzani U, Laqman M, Rojo J et al. Molecular associations on the T cell surface correlate with immunological memory. Eur. J. Immunol. 1990; 20: 2249-57.
118. Donovan JA, Goldman FD, Koretzky GA. Restoration of CD2-mediated signalling by a chimeric membrane protein including the cytoplasmic sequence of CD45. Hum. Immunol. 1994; 40: 123-30.
119. Wegener A, Letourneur F, Hoeveier A, Brocker T, Luton F, Malissen B. The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 1992; 68: 83-95.
120. Geisler C. The T cell receptor: structural and functional studies. Danish Med. Bull. 1995; 42: 342-57.
121. Malissen B, Malissen M. Functions of TCR and pre-TCR subunits: lessons from gene ablation. Curr. Opin. Immunol. 1996; 8: 383-93.
122. Weiss A. T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein tyrosine kinases. Cell 1993; 73: 209-12.
123. Malissen B, Schmitt-Verhulst A. Transmembrane signalling through the T-cell-receptor-CD3 complex. Curr. Opin. Immunol. 1993; 5: 324-33.
124. Kolanus W, Romeo C, Seed B. T cell activation by clustered tyrosine kinases. Cell 1993; 74: 171-83.
125. Mustelin T, Burn P. Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem. Sci. 1993; 18: 215-20.
126. Rudd CE, Janssen O, Prasad KVS et al. Src-related protein tyrosine kinases and their surface receptors. Biochim. Biophys. Acta. 1993; 1155: 239-66.
127. Isakov N. Immunoreceptor tyrosine-based activation motif (ITAM), a unique module linking antigen and Fc receptors to their signaling cascades. J. Leuk. Biol. 1997; 61: 6-16.
128. Isakov N, Wange RL, Samelson LE. The role of tyrosine kinases and phosphotyrosine-containing recognition motifs in regulation of the T cell-antigen receptor-mediated signal transduction pathway. J. Leuk. Biol. 1994; 55: 265-71.
129. Howe LR, Weiss A. Multiple kinases mediate T-cell-receptor signalling. Trends Biochem. Sci. 1995; 20: 59-64.
130. Bolen JB. Protein tyrosine kinases in the initiation of antigen receptor signalling. Curr. Opin. Immunol. 1995; 7: 306-11.
131. Iwashima M, Irving BA, van Oers NSC, Chan AC, Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994; 263: 1136-8.
132. Hivroz C, Fischer A. Multiple roles for ZAP-70. Curr. Biol. 1994; 4: 731-3.
133. Wange RL, Malek SN, Desiderio S, Samelson LE. Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor ζ and CD3 from activated Jurkat T cells. J. Biol. Chem. 1993; 268: 19797-801.
134. van Oers NS, Killeen SC, Weiss A. ZAP-70 is constitutively associated with tyrosine phosphorylated TCR zeta in murine thymocytes and lymph node T cells. Immunity 1994; 1: 675-85.
135. lck. Immunity 1996; 4: 495-504.
136. Chan AC, Dalton M, Johnson R et al. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 required for lymphocyte antigen receptor function. EMBO J. 1995; 14: 2499-508.
137. Wange RL, Guitan R, Isakov N, Watts JD, Aebersold R, Samelson LE. Activating and inhibiting mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 1995; 270: 18 730-3.
138. lck. J. Biol. Chem. 1996; 271: 10 054-9.
139. Beyers AD, Spruyt LL, Williams AF. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc. Natl Acad. Sci. USA 1992; 89: 2945-9.
140. Wange RL, Samelson LE. Complex complexes: signalling at the TCR. Immunity 1996; 5: 197-205.
141. Rudd CE, Janssen O, Cai Y-C, da Silva A, Raab M, Prasad KVS. Two-step TCRζ/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases. Immunol. Today 1994; 15: 225-34.
142. Wardenburg JB, Fu C, Jackman JK et al. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J. Biol. Chem. 1996; 271: 19641-4.
143. Ghosh J, Miller RA. Rapid tyrosine phosphorylation of Grb2 and Shc in T cells exposed to anti-CD3, anti-CD4 and anti-CD45 stimuli: differential effects of aging. Mech. Ageing Dev. 1995; 80: 171-87.
144. Mege D, Di Bartolo V, Germain V, Tuosto L, Michel F, Acuto O. Mutation of tyrosines 492-493 in the kinase domain of ZAP-70 affects multiple T cell receptor signalling pathways. J. Biol. Chem. 1996; 271: 32 644-52.
145. Fyn and ZAP-70, in T cell signalling. J. Immunol. 1996; 156: 1369-77.
146. Latour S, Chow LML, Veillette A. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. J. Biol. Chem. 1996; 271: 22 782-90.
147. Szamel M, Resch K. T cell antigen receptor-induced signal transduction pathways: activation and function of protein kinases C in T lymphocytes. Eur. J. Biochem. 1995; 228: 1-15.
148. Edwards DR. Cell signalling and the control of gene transcription. Trends Pharm. Sci. 1994; 15: 239-44.
149. Rao A. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 1994; 15: 274-81.
150. Ward SG, June CH, Olive D. PI 3-kinase: a pivotal pathway in T-cell activation? Immunol. Today 1996; 17: 187-97.
151. Woodrow MA, Rayter S, Downward J, Cantrell DA. p21ras function is important for T cell antigen receptor and protein kinase C regulation of nuclear factor of activated T cells. J. Immunol. 1993; 150: 3853-61.
152. Lim L, Manser E, Leung T, Hall C. Regulation of phosphorylation pathways by p21 GTPases: The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur. J. Biochem. 1996; 242: 171-85.
153. Izquiedro-Pastor M, Rief K, Cantrell D. The regulation and function of p21ras during T cell activation and growth. Immunol. Today 1995; 16: 159-64.
154. lck protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase-deficient mice. J. Exp. Med. 1995; 181: 345-9.
155. Byth KF, Conroy LA, Howlett S et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J. Exp. Med. 1996; 183: 1707-18.
156. Pingel JT, Thomas ML. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 1989; 58: 1055-65.
157. Peyron J-F, Verma S, de Waal Malefyt R, Sancho J, Terhorst C, Spits H. The CD45 protein tyrosine phosphatase is required for the completion of the activation program leading to lymphokine production in the Jurkat human T cell line. Int. Immunol. 1991; 3: 1357-66.
158. Koretzky G, Picus J, Thomas ML, Weiss A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 1990; 346: 66-8.
159. Weber JR, Bell GM, Han MY, Pawson T, Imboden JB. Association of the tyrosine kinase lck with phospholipase C-γ1 after stimulation of the T cell antigen receptor. J. Exp. Med. 1992; 176: 373-9.
160. Kanner SB, Deans JP, Ledbetter JA. Regulation of CD3-induced phospholipase C-gamma1 (PLCγ1) tyrosine phosphorylation by CD4 and CD45 receptors. Immunology 1992; 75: 441-7.
161. fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx. EMBO J. 1992; 11: 4887-97.
162. 2+ oscillations. J. Exp. Med. 1992; 176: 835-44.
163. Cahir McFarland ED, Hurley TR, Pingel JT, Sefton BM, Shaw A, Thomas ML. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signalling through the T-cell receptor. Proc. Natl Acad. Sci. USA 1993; 90: 1402-6.
164. fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 1992; 22: 1173-8.
165. Koretzky GA, Kohmetscher M, Ross S. CD45-associated kinase activity requires lck but not T cell receptor expression in the Jurkat T cell line. J. Biol. Chem. 1993; 268: 8958-64.
166. Burns CM, Sakaguchi K, Appella E, Ashwell JD. CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. J. Biol. Chem. 1994; 269: 13 594-600.
167. D'Oro U, Sakaguchi K, Appella E, Ashwell JD. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol. Cell. Biol. 1996; 16: 4996-5003.
168. Ross SE, Schraven B, Goldman FD, Crabtree J, Koretzky GA. The association between CD45 and lck does not require CD4 or CD8 and is independent of T cell receptor stimulation. Biochem. Biophys. Res. Commun. 1994; 198: 88-96.
169. Sieh M, Bolen JB, Weiss A. CD45 specifically modulates binding of lck to a phosphopeptide encompassing the negative regulatory tyrosine of lck. EMBO J. 1993; 12: 315-21.
170. zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 1995; 25: 942-6.
171. Imbert V, Farahifar D, Auberger P, Mary D, Rossi B, Peyron JF. Stimulation of the T cell antigen receptor-CD3 complex signalling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or ZAP-70-dependent signalling pathways. J. Inflamm. 1996; 46: 65-77.
172. Okumura M, Thomas ML. Regulation of immune function by protein tyrosine phosphatases. Curr. Opin. Immunol. 1995; 7: 312-19.
173. Matozaki T, Kasuga M. Roles of protein tyrosine phosphatases in growth factor signalling. Cell. Signal. 1996; 8: 13-19.
174. Minami Y, Stafford FJ, Lippincott-Schwartz J, Yuan LC, Klausener RD. Novel redistribution of an intracellular pool of CD45 accompanies T cell activation. J. Biol. Chem. 1991; 266: 9222-30.
175. Deans JP, Serra HM, Shaw J, Shen YJ, Torres RM, Pilarski LM. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation. J. Biol. Chem. 1992; 148: 1898-905.
176. Tonks NK, Diltz CD, Fischer H. CD45, an integral membrane protein tyrosine phosphatase. J. Biol. Chem. 1990; 265: 10674-80.
177. Hovis RR, Donovan JA, Musci MA et al. Rescue of signalling by a chimeric protein containing the cytoplasmic domain of CD45. Science 1993; 260: 544-6.
178. Volarevic S, Niklinska BB, Burns CM, June CH, Weissman AM, Ashwell JD. Regulation of TCR signalling by CD45 lacking transmembrane and extracellular domains. Science 1993; 260: 541-7.
179. Goldman SJ, Uniyal S, Ferguson LM, Golan DE, Burakoff SJ, Kiener PA. Differential activation of phosphotyrosine protein phosphatase activity in a murine T cell hybridoma by monoclonal antibodies to CD45. J. Biol. Chem. 1992; 267: 6197-204.
180. Desai DM, Sap J, Schlessinger J, Weiss A. Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase. Cell 1993; 73: 541-54.
181. + T cells. Eur. J. Immunol. 1995; 25: 2445-51.
182. Novak TJ, Farber D, Leitenberg D, Hong S, Johnson P, Bottomly K. Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1994; 1: 109-19.
183. Chui D, Ong CJ, Johnson P, Teh H-S, Marth JD. Specific CD45 isoforms differentially regulate T cell receptor signaling. EMBO J. 1994; 13: 798-807.
184. Torimoto Y, Dang NH, Streuli M et al. Activation of T cells through a T cell-specific epitope of CD45. Cell. Immunol. 1992; 145: 111-29.
185. + human T lymphocyte subsets. Eur. J. Immunol. 1993; 23: 61-8.
186. + T cells exhibit similar CD3/T cell receptor-mediated transmembrane signaling capacities but differ in response to costimulatory signals. Eur. J. Immunol. 1994; 24: 1391-5.
187. + T cell subsets. Cell. Immunol. 1992; 141: 10-20.
188. + human T lymphocytes. J. Immunol. 1994; 152: 2830-6.
189. Onodera H, Motto DG, Koretzky GA, Rothstein DM. Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase. J. Biol. Chem. 1996; 271: 22225-30.
190. + primary T cells. Eur. J. Immunol. 1994; 24: 967-73.
191. McKenney DW, Onodera H, Gorman L, Mimura T, Rothstein DM. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving vav in T cells. J. Biol. Chem. 1995; 270: 24 949-54.
192. Rothstein DM, Saito H, Streuli M, Schlossman SF, Morimoto C. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors. J. Biol. Chem. 1992; 267: 7139-47.
193. Takeda A, Wu JJ, Maizel AL. Evidence for monomeric and dimeric forms of CD45 associated with a 30-kDa phosphorylated protein. J. Biol. Chem. 1992; 267: 16 651-9.
194. Bilwes AM, den Hertog J, Hunter T, Noel JP. Structural basis for inhibition of receptor protein tyrosine phosphatase-alpha by dimerization. Nature 1996; 382: 555-9.
195. Autero M, Gahmberg CG. Phorbol diesters increase the phosphorylation of the leukocyte common antigen CD45 in human T cells. Eur. J. Immunol. 1987; 17: 1503-6.
196. Stover DR, Charbonneau H, Tonks NK, Walsh KA. Protein-tyrosine-phosphatase CD45 is phosphorylated transiently on tyrosine upon activation of Jurkat T cells. Proc. Natl Acad. Sci. USA 1991; 88: 7704-7.
197. Ostergaard HL, Trowbridge IS. Negative regulation of CD45 protein tyrosine phosphatase activity by ionomycin in T cells. Science 1991; 253: 1423-5.
198. lck tyrosine kinase and activates the phosphatase. Mol. Cell. Biol. 1994; 14: 1308-21.
199. Lokeshwar VB, Bourguignon LYW. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J. Biol. Chem. 1992; 267: 21 551-7.
200. Cemy J, Stockinger H, Horejsi V. Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 1996; 26: 2335-43.
201. Verhagen AM, Schraven B, Wild M, Wallich R, Meuer SC. Differential interaction of the CD2 extracellular and intracellular domains with the tyrosine phosphatase CD45 and the ζ chain of the TCR/CD3/ζ complex. Eur. J. Immunol. 1996; 26: 2841-9.
202. + thymocytes from apoptosis. Int. Immunol. 1996; 8: 1947-53.
203. Harnett M, Rigley K. The role of G-proteins versus protein tyrosine kinases in the regulation of lymphocyte activation. Immunol. Today 1992; 13: 482-6.
204. Kitamura K, Maiti A, Ng DH, Johnson P, Maizel AL, Takeda A. Characterisation of the interaction between CD45 and CD45-AP. J. Biol. Chem. 1995; 270: 21 151-7.
205. Bruyns E, Hendricks-Taylor LR, Meuer S, Koretzky GA, Schraven B. Identification of the sites of interaction between lymphocyte phosphatase-associated phosphoprotein (LPAP) and CD45. J. Biol. Chem. 1995; 270: 31 372-6.
206. Cahir McFarland ED, Thomas ML. CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region. J. Biol. Chem. 1995; 270: 28 103-7.
207. Bork P, Sudol M. The WW domain: a signalling site in dystrophin? Trends Biochem. Sci. 1994; 19: 531-3.
208. Sudol M. Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 1996; 65: 113-32.
209. lck T cell receptor complexes. Science 1991; 254: 439-41.
210. lck tyrosine kinases in human T cells. EMBO J. 1994; 13: 1920-9.
211. Kitamura K, Matsudo A, Motoya S, Takeda A. CD45-associated protein is a lymphocyte-specific membrane protein expressed in two distinct forms. Eur. J. Immunol. 1997; 27: 383-8.
212. Peter ME, Hall C, Ruhlmann A, Sancho J, Terhorst C. The T cell receptor C chain contains a GTP/GDP binding site. EMBO J. 1992; 11: 933-41.
213. lck and the cytoplasmic domain of CD45 in vitro. J. Biol. Chem. 1996; 271: 1295-300.
214. Pratt JC, Ravichandran KS, Sawasdikosol S, Chang J-H, Burakoff SJ. Multifunctional roles of adapter proteins in T-cell signalling. Immunologist 1996; 4: 122-7.
215. Streuli M. Protein tyrosine phosphatases in signalling. Curr. Opin. Cell Biol. 1996; 8: 182-8.
216. Shimizu Y, Sugiyama H, Fujii Y et al. Lineage- and differentiation stage-specific expression of LSM-1 (LPAP), a possible substrate for CD45, in human hematopoietic cells. Am. J. Hematol. 1997; 51: 1-11.